Medicare Guidance - Fidelity Brokerage Services LLC 提醒用户注意 Medicare 相关的省钱事项 [1] - 该信息可能旨在帮助用户避免在 Medicare 方面犯代价高昂的错误 [1] Regulatory Information - Fidelity Brokerage Services LLC 是 NYSE（纽约证券交易所）和 SIPC（证券投资者保护公司）的成员 [1] - Fidelity Brokerage Services LLC 的地址是 900 Salem Street, Smithfield, RI 02917 [1]

As the government shutdown continues, Congress can’t come to terms on spending, including for Medicaid. It’s easy to confuse Medicare with Medicaid, but there are several key differences. Here’s what you should know. https://t.co/2awowYCqpi ...

As Congress Fights Over Benefits, Here’s A Quick Look At Medicare And Medicaidhttps://t.co/Bs043RNjrt https://t.co/5K5xLG5wjM ...

Government Shutdown Impact - Hundreds of thousands of non-essential federal workers will be furloughed, impacting their regular paychecks, though retroactive pay is expected [1] - A government shutdown lasting less than approximately 2 weeks is projected to have minimal financial and economic repercussions [2] - Social Security and Medicare benefits are expected to continue without interruption during the shutdown [3] - Disruptions are anticipated in certain government services, including some Social Security services, housing programs, nutrition assistance, and veteran claims [3] - National parks and monuments will be closed during the shutdown [4] - Potential disruptions to travel plans may occur due to TSA agents and air traffic controllers possibly not reporting to work without pay [4] - The federal flood insurance program will be closed to new policies during the shutdown, potentially affecting home buyers needing flood insurance to secure a mortgage [5] - Healthcare premiums for millions are indirectly affected by government shutdown negotiations, with potential doubling in 2026 if enhanced subsidies are not extended [5][6] - Market analysts suggest the stock market has generally been resilient during past government shutdowns [6] - Market analysts suggest potential market dips during the shutdown could present buying opportunities for investors [7]

Overnight, Capitol Hill put up a big close for business sign. I'm sure when you woke up this morning, you had a lot of questions about how this is going to impact your daily life, like, "What about my mom's Medicaid? Will my 401k be affected?" Maybe you asked, "Why do I even need to care?" So, we decided to phone some friends around NBC News and get some of these questions answered for you. I'm a little less worried about Wall Street because Wall Street stock market prices reflect corporate profits and comp ...

Pharmaceutical Sector Analysis - The pharmaceutical space has been under pressure, leading to cheaper multiples [1] - The industry is attractive due to its lack of correlation with AI and strong balance sheets [2] - Healthcare sector positioning is underweight, providing sustainability [3][4] - Medicare's low percentage of revenues for the sector makes government negotiation a win [5] - Valuations of many companies are at multi-year EPS relative value [6] Company Specifics (Fizer) - Fizer's deal with Metera and mid-stage readout of the long-acting GLP1 drug are turning points [7] - Fizer has allocated 70 billion USD for R&D and capex spend [5] Market Dynamics - Generalist investors are overweight in technology and may rotate into the pharmaceutical space [10] - The market doesn't care about a government shutdown [14] Valuation - Bristol is trading at 85 times next year's earnings, and Merc is probably about the same [9] - Giving Bristol a 12 multiple quickly makes it a 72 USD stock, and Merc a 120 USD stock [9]

Democrats have repeatedly made clear. We are ready to sit down with anyone at any time and at any place in order now to reopen the government to enact a spending agreement that meets the needs of the American people. And to address the devastating Republican health care crisis.That has caused extraordinary harm on people all across the country. In rural America, working class America, urban America, small town America, the heartland of America and black and brown communities throughout America. The Republic ...

GOP is repeating what the New York Times calls a new and misleading talking point that Democrats are shutting down the government to fund free health care for unauthorized immigrants. The false assertion, false, has been repeated by Vice President J. D.Vance and Speaker Mike Johnson along with the president himself. Here's what is important to note. Undocumented immigrants have long been prohibited from taxpayer funded Medicaid coverage except for treatment in emergency medical situations.They also do not q ...

Fidelity Brokerage Services LLC, Member NYSE, SIPC, 900 Salem Street, Smithfield, RI 02917 ...

Market Dynamics & Drug Pricing - President Trump announced a deal with Pfizer to sell medication directly to consumers through Trump RX, contingent on US manufacturing investment [1] - Drug company stocks experienced an increase following the announcement [3] - The initiative aims to address concerns about drug pricing, building upon the Inflation Reduction Act's price controls in Medicare and Medicaid [4] - Pfizer emphasized the voluntary nature of its participation in Trump RX [4] - Drug companies typically receive less than 50% of the list price due to pharmacy benefits managers (PBMs) and other intermediaries [6] - Pharmaceutical Research and Manufacturing Association is launching America's Medicines com to allow direct access to drug pricing [6][7] - Concerns exist that drug companies might raise prices in Europe to match lowered US prices [10] - Bristol Myers Squibb will sell its new anti-psychotic drug in Europe at the same price as in the US [11] Impact on Stakeholders - Direct drug sales could be devastating to PBMs and insurance companies [9] - Reduced income for drug companies could negatively impact R&D, as 25% of drug sales go into R&D [12] - A hypothetical $100 billion reduction in industry income could result in $25 billion less for R&D, equivalent to 60% of the NIH's R&D budget [13] Lucarin & Drug Shortages - The FDA's announcement regarding Lucarin for autism led to a surge in demand and subsequent shortages [15][16] - Lucarin, a generic drug used to mitigate toxicities from methotrexate in cancer and rheumatoid arthritis patients, is now difficult to obtain [16][17] - The increased demand for Lucarin, driven by the White House announcement, has strained existing supplies [19] - Manufacturers are expected to increase production of Lucarin to address the shortage, but the timeline remains uncertain [20][21]